Portfolio company
BioAtla®
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops conditionally active antibody therapeutics for the treatment of various cancers in clinical-stage patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CytomX
This biopharmaceutical company develops conditionally activated antibody therapeutics for oncology patients and healthcare providers.
TORL BioTherapeutics
This biopharmaceutical company develops antibody-drug conjugates and monoclonal antibodies to treat various cancers for patients with unmet medical needs.
Profound Bio
This clinical-stage biotechnology company develops antibody-drug conjugates and targeted therapies for patients with solid tumors and hematological malignancies.
Callio Therapeutics
The company develops multi-payload antibody-drug conjugates to treat cancer patients.
Adcendo
This clinical-stage biotechnology company develops antibody-drug conjugates to treat patients with various types of cancer and high unmet medical needs.
ATB Therapeutics
The company develops engineered antibody therapies for patients with cancer and autoimmune diseases using a proprietary bioengineering platform.
Adcytherix
This biopharmaceutical company develops novel antibody-drug conjugates to treat various forms of cancer for patients with high unmet clinical needs.
Pionyr Immunotherapeutics
This company develops antibody therapeutics that modify the tumor microenvironment to treat cancer patients.